MONOPAR THERAPEUTICS |
USA |
Gesundheit |
US61023L2079 / A40JML |
1IY0 (Frankfurt) / MNPR (NASDAQ) |
FRA:1IY0, ETR:1IY0, 1IY0:GR, NASDAQ:MNPR |
- |
https://www.monopartx.com.. |
Monopar Therapeutics Inc., a clinical-stage biopha..
>Volltext.. |
258.81 Mio. EUR |
213.7 Mio. EUR |
- |
-16.28 Mio. EUR |
-14.75 Mio. EUR |
-3.28 EUR |
0.1 Mio. EUR |
33.67 Mio. EUR |
-8.36 Mio. EUR |
33.63 |
- |
-120.91% |
- |
- |
- |
- |
MONOPAR |
14.09.25 |
|
||||
|
||||
|
||||
|
||||
|